- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Pralsetinib is a targeted therapy drug primarily used for non-small cell lung cancer and thyroid cancer with specific gene mutations. The usage...
The management of side effects of Pralsetinib should focus on rash, pancreatitis, and hypertension. The following are specific measures and p...
Diarrhea, fatigue, and hand foot syndrome during treatment with Lenvatinib are common adverse reactions that require targeted preventive measur...
Lenvatinib has clear contraindications in patients with severe liver and kidney dysfunction and pregnant women, and strict adherence to medicat...
Lenvatinib, as a multi-target tyrosine kinase inhibitor, should be given special attention to adverse reactions such as hypertension, proteinur...
Lenvatinib is a multi-target tyrosine kinase inhibitor primarily used for the treatment of malignant tumors such as thyroid cancer, renal cell ...
Cabozantinib is a multi-target tyrosine kinase inhibitor that is suitable for the treatment of various cancers. The dosage should be adjusted a...
When taking cabozantinib, attention should be paid to fasting or with meals, and the principles of missed doses and discontinuation of medicati...
Cabozantinib is contraindicated for patients with severe liver injury and active bleeding, as its use may pose a fatal risk. The following item...
During the use of cabozantinib, special attention should be paid to monitoring and managing hypertension, diarrhea, and hand foot syndrome. H...
